IBM heads into the final weeks of summer with its most significant story buried in the short interest data: bears have been covering aggressively, even as the stock pulled back on the week and the Street continues to quietly trim targets.
The clearest development in the data is the collapse in short positioning. Short interest has fallen 32% over the past week to 2.2% of the free float — and is down more than 40% over the past month. To put that in context, shorts were running near 3.9% of float in mid-July. That cover-down has been rapid and sustained, not a one-session blip. The borrow market reflects no stress: availability is extraordinarily loose at nearly 2,925%, meaning there are roughly 29 shares available to borrow for every one currently lent out. Cost to borrow is a negligible 0.34%. The ORTEX short score has also drifted lower this week, easing from 35.5 on August 10 to 31.6 now — consistent with a market that is becoming less interested in pressing the short side. Options traders are not sounding any alarm either; the put/call ratio is running at 0.75, slightly below its 20-day average, suggesting options positioning is broadly neutral to modestly bullish rather than defensive.
The Street picture is more complicated. Analyst consensus remains among the most constructive in the sector — the recommendation differential ranks in the 95th percentile across the universe, unchanged from the prior note — but the round of post-Q2 target cuts in late July was notable in both breadth and magnitude. Morgan Stanley trimmed its target from $293 to $190, while Barclays cut from $350 to $262 across two separate actions around the earnings date. Susquehanna brought its target down from $303 to $225. The consensus mean price target now sits at roughly $245, implying about 5% upside from the current $232.67 close — not a wide margin. Bulls point to IBM's durable cash generation, AI infrastructure positioning, and one of the highest dividend scores in the universe. Bears counter that forward EPS growth ranks near the bottom of the peer group at the 12th percentile year-on-year, and that the consulting cycle remains under pressure in the current capex environment. EPS momentum is soft on both the 30-day and 90-day windows, ranking in the 36th and 23rd percentiles respectively — a continuation of the pattern flagged in the prior note rather than a fresh deterioration.
The peer group has also had a difficult week. KD dropped 7.7% and HCKT fell 8.3%, making IBM's 2.4% weekly decline look comparatively measured. ACN and DXC both lost ground too, suggesting the IT consulting sector broadly faced selling pressure rather than anything IBM-specific driving the slide.
The historical earnings reaction pattern is worth noting ahead of the October 21 print. After Q2 results in July, IBM fell 1.8% the next day but recovered to gain 7.6% over the following five sessions — a pattern that rewarded patience. The April print produced a flat immediate reaction with minimal five-day follow-through. The asymmetry in those two episodes — sharp initial dip, then recovery — may be part of why short sellers are choosing to step back now rather than press into the next quarterly event.
With October 21 as the next focal point, the setup to watch is whether the gap between an unusually bullish analyst consensus and subdued forward earnings growth estimates begins to close — either through estimate upgrades or through further target compression from a Street that has already moved aggressively lower once this quarter.
See the live data behind this article on ORTEX.
Open IBM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
